B12 deficiency can impair this process and prevent the use of storage form of folate when needed, resulting in functional folate deficiency
The Food and Drug Administration (FDA) warns the general public from purchasing and using the non-compliant cosmetic product TOKYO WHITE GLUTATHIONE, VITAMINS C & E, WITH NATURAL WHITENING INGREDIENTS AND ANTI-OXIDANTS NATURAL WHITENING AND MOISTURIZING FACE & BODY SOAP
A study systematically reviewed GTC and its pure form, EGCG, in pre-clinical animal trials
In spite of a large body of evidences showing that poor riboflavin status interferes with various metabolic processes, the mechanisms of these abnormalities have not been well elucidated so far yet
Factors that may suggest an immune-mediated component and potential benefit from IVIG include: Clinical Features Rapid onset or progression of symptoms Non-length-dependent pattern (symptoms not limited to feet/hands) Associated autonomic symptoms Lack of other evident causes (diabetes, toxins, etc.) Family history of autoimmune disease Laboratory Findings Presence of autoantibodies (even non-specific ones) Elevated inflammatory markers Evidence of complement activation Abnormal immunoglobulin levels or patterns Diagnostic Test Results Skin biopsy showing inflammatory infiltrates along with reduced fiber density Abnormal autonomic testing consistent with SFN Normal or minimally abnormal nerve conduction studies (ruling out large fiber involvement) Response to Initial Therapies Inadequate response to standard neuropathic pain medications Partial response to corticosteroids or other immunosuppressants Temporal association with infections, vaccines, or immune stressors The IVIG Treatment Protocol For patients with refractory SFN who are deemed appropriate candidates, IVIG therapy typically follows a structured protocol: Dosing and Administration Initial treatment: 2 g/kg divided over 2-5 consecutive days Maintenance: 1 g/kg every 3-4 weeks Treatment duration: Initially 3-6 months with periodic reassessment The optimal duration of therapy remains somewhat individualized
BPC-157 heals from the gut outward while GHK-Cu rebuilds tissue structure
